Shuolong Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shuolong Li has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Guoyong Ding
Shandong First Medical University
2 shared publications - Xinyue Yin
Shandong First Medical University
2 shared publications Daiyu Song
Shandong First Medical University
1 shared publication- Shanshan Li
School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China
1 shared publication - Shuhan Zhao
S. Zhao, MPH, Department of Epidemiology, School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China
1 shared publication - Yuanzhi Peng
Y. Peng, MPH, Department of Epidemiology, School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China
1 shared publication
Latest Publications
- Open Access
- 10 August 2026
- Published by SAGE Publications in Journal of Alzheimer's Disease Reports
- Vol. 10
Association of HIV infection with dementia and cognitive impairment: A systematic review and meta-analysis
Background: With the widespread use of antiretroviral therapy, people living with HIV (PLWH) are experiencing increased life expectancy, accompanied by a growing burden of age-related comorbidities. Cognitive impairment and dementia have been increasingly reported among PLWH; however, epidemiological evidence regarding their association remains inconsistent. Objective: This systematic review and meta-analysis aimed to evaluate the association between HIV infection and the risk of dementia and cognitive impairment. Methods: We systematically searched PubMed, Embase, Web of Science, and the Cochrane Library from inception to March 4, 2026 for cohort studies investigating the association between HIV infection and dementia or cognitive impairment. Study selection, data extraction, and quality assessment using the Newcastle-Ottawa Scale were independently conducted by two reviewers. Heterogeneity across studies was assessed using Q test and I 2 statistics. Pooled relative risks (RRs) with 95% confidence intervals (CIs) were calculated using fixed- or random-effects models as appropriate. Subgroup, sensitivity, and publication bias analyses were performed. Results: A total of 9 articles were eligible for this analysis. The pooled results showed that HIV infection was significantly associated with an increased risk of dementia and cognitive impairment (RR=2.07, 95% CI: 1.35, 3.17). Substantial heterogeneity was observed across studies ( I 2 =93.7%). Subgroup analyses suggested that publication year, baseline immunological status, and age distribution might partially explain the observed heterogeneity. Sensitivity analysis confirmed the robustness of the findings, and no significant publication bias was detected. Conclusions: This meta-analysis suggests that HIV infection is associated with an increased risk of dementia and cognitive impairment.
- 10 August 2026
- Published by SAGE Publications in Journal of Alzheimer's Disease Reports
- Vol. 10
Open AccessAssociation of HIV infection with dementia and cognitive impairment: A systematic review and meta-analysis
Background: With the widespread use of antiretroviral therapy, people living with HIV (PLWH) are experiencing increased life expectancy, accompanied by a growing burden of age-related comorbidities. Cognitive impairment and dementia have been increasingly reported among PLWH; however, epidemiological evidence regarding their association remains inconsistent. Objective: This systematic review and meta-analysis aimed to evaluate the association between HIV infection and the risk of dementia and cognitive impairment. Methods: We systematically searched PubMed, Embase, Web of Science, and the Cochrane Library from inception to March 4, 2026 for cohort studies investigating the association between HIV infection and dementia or cognitive impairment. Study selection, data extraction, and quality assessment using the Newcastle-Ottawa Scale were independently conducted by two reviewers. Heterogeneity across studies was assessed using Q test and I 2 statistics. Pooled relative risks (RRs) with 95% confidence intervals (CIs) were calculated using fixed- or random-effects models as appropriate. Subgroup, sensitivity, and publication bias analyses were performed. Results: A total of 9 articles were eligible for this analysis. The pooled results showed that HIV infection was significantly associated with an increased risk of dementia and cognitive impairment (RR=2.07, 95% CI: 1.35, 3.17). Substantial heterogeneity was observed across studies ( I 2 =93.7%). Subgroup analyses suggested that publication year, baseline immunological status, and age distribution might partially explain the observed heterogeneity. Sensitivity analysis confirmed the robustness of the findings, and no significant publication bias was detected. Conclusions: This meta-analysis suggests that HIV infection is associated with an increased risk of dementia and cognitive impairment.
- 15 July 2026
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 53 (11) , 1221-1228
Associations of Physical Activity Levels With Depressive Symptoms Among Patients With Radiographic Axial Spondyloarthritis: A Cross-Sectional Study
Objective: This study aimed to examine the associations between physical activity (PA) levels and depressive symptoms in patients with radiographic axial spondyloarthritis (r-axSpA). Methods: We conducted a cross-sectional analysis of patients with r-axSpA identified from the UK Biobank. Total PA (TPA) was assessed using a modified version of the International Physical Activity Questionnaire Short Form (IPAQ-SF), and leisure-time PA (LTPA) was derived from self-reported frequency and duration of 5 leisure activities during the preceding 4 weeks. Depressive symptoms were assessed using the 2-item Patient Health Questionnaire (PHQ-2). Multivariable logistic regression models were used to examine the associations between PA levels and depressive symptoms. Results: Among 1542 patients with r-axSpA, those engaging in moderate-level PA had the lowest prevalence of depressive symptoms. After full adjustment, moderate-level TPA was associated with lower odds of depressive symptoms compared with low-level TPA (odds ratio [OR] 0.55, 95% CI 0.36-0.82), whereas the association with high-level TPA was not statistically significant (OR 0.63, 95% CI 0.39-1.01). Moderate-level LTPA was also associated with lower odds of depressive symptoms (OR 0.58, 95% CI 0.34-0.996), whereas low- and high-level LTPA showed no significant associations after full adjustment. Conclusion: Moderate-level PA was associated with a lower prevalence of depressive symptoms in patients with r-axSpA, whereas associations for high-level PA were less consistent. Our findings suggest that PA levels may be an important correlate of depressive symptoms in patients with r-axSpA, warranting confirmation in longitudinal studies.
- 15 July 2026
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 53 (11) , 1221-1228
Associations of Physical Activity Levels With Depressive Symptoms Among Patients With Radiographic Axial Spondyloarthritis: A Cross-Sectional Study
Objective: This study aimed to examine the associations between physical activity (PA) levels and depressive symptoms in patients with radiographic axial spondyloarthritis (r-axSpA). Methods: We conducted a cross-sectional analysis of patients with r-axSpA identified from the UK Biobank. Total PA (TPA) was assessed using a modified version of the International Physical Activity Questionnaire Short Form (IPAQ-SF), and leisure-time PA (LTPA) was derived from self-reported frequency and duration of 5 leisure activities during the preceding 4 weeks. Depressive symptoms were assessed using the 2-item Patient Health Questionnaire (PHQ-2). Multivariable logistic regression models were used to examine the associations between PA levels and depressive symptoms. Results: Among 1542 patients with r-axSpA, those engaging in moderate-level PA had the lowest prevalence of depressive symptoms. After full adjustment, moderate-level TPA was associated with lower odds of depressive symptoms compared with low-level TPA (odds ratio [OR] 0.55, 95% CI 0.36-0.82), whereas the association with high-level TPA was not statistically significant (OR 0.63, 95% CI 0.39-1.01). Moderate-level LTPA was also associated with lower odds of depressive symptoms (OR 0.58, 95% CI 0.34-0.996), whereas low- and high-level LTPA showed no significant associations after full adjustment. Conclusion: Moderate-level PA was associated with a lower prevalence of depressive symptoms in patients with r-axSpA, whereas associations for high-level PA were less consistent. Our findings suggest that PA levels may be an important correlate of depressive symptoms in patients with r-axSpA, warranting confirmation in longitudinal studies.